Patent Application: Dichrostachys glomerata for Anxiety and Stress Reduction
Summary
The USPTO has published a patent application (US20260083793A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, and food cravings, while improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.
What changed
This document is a patent application (US20260083793A1) filed with the USPTO by Shil Kothari. It describes methods and compositions utilizing Dichrostachys glomerata, specifically fruit pods in oral dosage forms (pill, capsule, liquid, lozenge, or tablet), aimed at reducing anxiety, food cravings, and stress in mammals. The application also claims benefits such as improved mood, physical and mental health, energy, and overall happiness.
As this is a patent application, it does not impose immediate regulatory obligations on businesses. However, it signals potential future developments in the therapeutics sector related to natural compounds for mental well-being. Companies in the pharmaceutical or dietary supplement industries may wish to monitor the progress of this patent application and similar filings for competitive intelligence and potential licensing opportunities.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL
Application US20260083793A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari
Abstract
Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing stress in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/48 A61K 9/0053 A61P 25/22
Filing Date
2024-09-25
Application No.
18896884
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.